Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
doi: 10.1186/s10020-025-01318-y 201 WangXWanJWangCTongYChenYWangXet al
For instance, MTL-CEBP, an RNA therapy targeting C/EBP, has shown encouraging outcomes from a phase I clinical trial for hepatocellular carcinoma, where it suppressed CXCR4 expression on immune cells attracted to the tumor microenvironment [85]
Knowing how effective the medications are, [the obesity medicine community] can certainly recommend medication in addition to lifestyle changes, said Juliana Simonetti, MD, an obesity medicine specialist and co-director of the Comprehensive Weight Management Program at the University of Utah in Salt Lake City, who was not involved in the ACP update
Effects of L-carnitine supplementation for women with polycystic ovary syndrome: a systematic review and meta-analysis
Claudia von Boeselager (38:54) energy
